TUDOR INVESTMENT CORP ET AL - ACELRX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$102,000
-49.8%
24,100
-54.2%
0.00%
-50.0%
Q1 2015$203,000
+222.2%
52,600
+361.4%
0.01%
+200.0%
Q3 2014$63,00011,4000.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 6,574,060$27,874,0001.68%
SENZAR ASSET MANAGEMENT, LLC 798,381$3,385,0000.58%
Cormorant Asset Management, LP 850,000$3,604,0000.48%
Palo Alto Investors LP 2,135,739$9,056,0000.40%
Opus Point Partners Management, LLC 99,959$424,0000.34%
Granahan Investment Management 1,582,237$6,709,0000.19%
Joel Isaacson & Co., LLC 70,660$300,0000.08%
MARINER INVESTMENT GROUP LLC 59,700$253,0000.06%
MYCIO WEALTH PARTNERS, LLC 75,000$318,0000.06%
Cornerstone Capital, Inc. 59,200$251,0000.06%
View complete list of ACELRX PHARMACEUTICALS INC shareholders